ORAGENICS, INC. Employee Benefits and Share-based Compensation
ORAGENICS, INC. (OGEN) reported Employee Benefits and Share-based Compensation of $122.75 thousand for the 3-month period ending 2017-06-30, per its 10-Q filed 2017-08-14.
Discontinued › Notes › Compensation Related Costs
us-gaap:EmployeeBenefitsAndShareBasedCompensation · last filed 2017-08-14
- ORAGENICS, INC. employee benefits and share-based compensation for the quarter ending 2017-06-30 was $122.75K, a 224.70% increase year-over-year.
- ORAGENICS, INC. employee benefits and share-based compensation for the quarter ending 2017-03-31 was $172.02K, a 16.40% decline year-over-year.
- ORAGENICS, INC. employee benefits and share-based compensation for the quarter ending 2016-09-30 was $225.43K, a 17.35% decline year-over-year.
- ORAGENICS, INC. employee benefits and share-based compensation for the quarter ending 2016-06-30 was $37.80K, a 86.21% decline year-over-year.
| Period end | Employee Benefits and Share-based Compensation 3 month | Employee Benefits and Share-based Compensation 6 month | Employee Benefits and Share-based Compensation 9 month |
|---|---|---|---|
| 2017-06-30 | $122.75K 10-Q · filed 2017-08-14 | $294.77K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $172.02K 10-Q · filed 2017-05-15 | ||
| 2016-09-30 | $225.43K 10-Q · filed 2016-11-14 | $263.23K derived: sum of 2 quarters · filed 2017-08-14 | $468.99K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $37.80K 10-Q · filed 2017-08-14 | $243.56K 10-Q · filed 2017-08-14 | |
| 2016-03-31 | $205.76K 10-Q · filed 2017-05-15 | ||
| 2015-09-30 | $272.75K 10-Q · filed 2016-11-14 | $546.89K derived: sum of 2 quarters · filed 2016-11-14 | $659.03K 10-Q · filed 2016-11-14 |
| 2015-06-30 | $274.14K 10-Q · filed 2016-08-15 | $386.28K 10-Q · filed 2016-08-15 | |
| 2015-03-31 | $112.14K 10-Q · filed 2016-05-16 | ||
| 2014-09-30 | $34.11K 10-Q · filed 2015-11-06 | $285.29K derived: sum of 2 quarters · filed 2015-11-06 | $290.83K 10-Q · filed 2015-11-06 |
| 2014-06-30 | $251.18K 10-Q · filed 2015-08-07 | $256.72K 10-Q · filed 2015-08-07 | |
| 2014-03-31 | $5.54K 10-Q · filed 2015-05-08 | ||
| 2013-06-30 | $78.21K 10-Q · filed 2014-08-07 | $85.82K 10-Q · filed 2014-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |